Wondering about the most recent progress in Myasthenia Gravis treatments research and clinical trials?
Wondering about the most recent progress in myasthenia gravis treatments research and clinical trials?
Join a “What’s New in MG Research” webinar to learn about the latest research results, key clinical trial phases, and current outcomes from top research trials taking place right now.
A New Approach to Treating Generalized Myasthenia Gravis: KYY-101 CAR T-cell Therapy
November 13, 2025
2:00 PM Eastern | 11:00 AM Pacific
Kyverna’s investigational CAR T-cell therapy, KYV-101, is a type of immunotherapy that is different than current treatments for generalized MG (gMG). It is a single dose and works by using a person’s own immune cells to fight disease. During this webinar, we’ll learn more about how CAR T-cell therapies work and discuss an ongoing phase 3 clinical study, called KYSA-6, which is evaluating KYV-101 for patients living with gMG.
Sponsored by Kyverna
Register Now
Learn About IMAAVY (nipocalimab-aahu)
December 4, 2025
4:00 PM Eastern | 1:00 PM Pacific
This free program is for patients, caregivers, and the community to learn about generalized myasthenia gravis (gMG) and IMAAVY clinical data, the treatment journey, and resources and support.
This program will not be recorded, so please join us live.
Sponsored by Johnson & Johnson
Register Now
Presenting Partners
Recent Webinars
Taking Back Control in Myasthenia Gravis: Understanding What New and Upcoming Therapies Could Mean for You (In Partnership with NORD and MedLive) – 8/26/25
Watch the Replay
